Angiogenic response to bioactive glass promotes bone healing in an irradiated calvarial defect

Ann Leu, Susanne M. Stieger, Paul Dayton, Katherine W. Ferrara, Jonathan K Leach

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Localized radiation is an effective treatment modality for carcinomas, yet the associated reduction of the host vasculature significantly inhibits the tissue's regenerative capacity. Low concentrations of bioactive glass (BG) possess angiogenic potential, and we hypothesized that localized BG presentation would increase neovascularization and promote healing in an irradiated bone defect. An isolated calvarial region of Sprague-Dawley rats was irradiated 2 weeks before surgery. Bilateral critical-sized defects were created and immediately filled with a BG-loaded collagen sponge or an empty sponge as an internal control. Histological analysis of calvaria collected after 2 weeks demonstrated greater neovascularization within the defect in the presence of BG than with collagen alone. Noninvasive ultrasound imaging at 4 weeks detected less contrast agent in the brain below BG-treated defects than in the nearby untreated defects and images of treated defects acquired at 2 weeks. The reduced ability to detect contrast agent in BG-treated defects suggested greater attenuation of ultrasound signal due to early bone formation. Micro-computed tomography imaging at 12 weeks demonstrated significantly greater bone volume fraction within BG-treated defects than in controls. These results suggest that neovascularization induced by localized BG delivery promotes bone regeneration in this highly compromised model of bone healing and may offer an alternative approach to costly growth factors and their potential side-effects.

Original languageEnglish (US)
Pages (from-to)877-885
Number of pages9
JournalTissue Engineering - Part A
Volume15
Issue number4
DOIs
StatePublished - Apr 1 2009

Fingerprint

Bioactive glass
Glass
Bone
Bone and Bones
Defects
Porifera
Collagen
Contrast Media
Ultrasonics
Imaging techniques
Bone Regeneration
Osteogenesis
Skull
Surgery
Tomography
Sprague Dawley Rats
Rats
Ultrasonography
Volume fraction
Brain

ASJC Scopus subject areas

  • Bioengineering
  • Biochemistry
  • Biomedical Engineering
  • Biomaterials

Cite this

Angiogenic response to bioactive glass promotes bone healing in an irradiated calvarial defect. / Leu, Ann; Stieger, Susanne M.; Dayton, Paul; Ferrara, Katherine W.; Leach, Jonathan K.

In: Tissue Engineering - Part A, Vol. 15, No. 4, 01.04.2009, p. 877-885.

Research output: Contribution to journalArticle

Leu, Ann ; Stieger, Susanne M. ; Dayton, Paul ; Ferrara, Katherine W. ; Leach, Jonathan K. / Angiogenic response to bioactive glass promotes bone healing in an irradiated calvarial defect. In: Tissue Engineering - Part A. 2009 ; Vol. 15, No. 4. pp. 877-885.
@article{c3a823ae7e4847199a16c8788c86ef7e,
title = "Angiogenic response to bioactive glass promotes bone healing in an irradiated calvarial defect",
abstract = "Localized radiation is an effective treatment modality for carcinomas, yet the associated reduction of the host vasculature significantly inhibits the tissue's regenerative capacity. Low concentrations of bioactive glass (BG) possess angiogenic potential, and we hypothesized that localized BG presentation would increase neovascularization and promote healing in an irradiated bone defect. An isolated calvarial region of Sprague-Dawley rats was irradiated 2 weeks before surgery. Bilateral critical-sized defects were created and immediately filled with a BG-loaded collagen sponge or an empty sponge as an internal control. Histological analysis of calvaria collected after 2 weeks demonstrated greater neovascularization within the defect in the presence of BG than with collagen alone. Noninvasive ultrasound imaging at 4 weeks detected less contrast agent in the brain below BG-treated defects than in the nearby untreated defects and images of treated defects acquired at 2 weeks. The reduced ability to detect contrast agent in BG-treated defects suggested greater attenuation of ultrasound signal due to early bone formation. Micro-computed tomography imaging at 12 weeks demonstrated significantly greater bone volume fraction within BG-treated defects than in controls. These results suggest that neovascularization induced by localized BG delivery promotes bone regeneration in this highly compromised model of bone healing and may offer an alternative approach to costly growth factors and their potential side-effects.",
author = "Ann Leu and Stieger, {Susanne M.} and Paul Dayton and Ferrara, {Katherine W.} and Leach, {Jonathan K}",
year = "2009",
month = "4",
day = "1",
doi = "10.1089/ten.tea.2008.0018",
language = "English (US)",
volume = "15",
pages = "877--885",
journal = "Tissue Engineering - Part A",
issn = "1937-3341",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Angiogenic response to bioactive glass promotes bone healing in an irradiated calvarial defect

AU - Leu, Ann

AU - Stieger, Susanne M.

AU - Dayton, Paul

AU - Ferrara, Katherine W.

AU - Leach, Jonathan K

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Localized radiation is an effective treatment modality for carcinomas, yet the associated reduction of the host vasculature significantly inhibits the tissue's regenerative capacity. Low concentrations of bioactive glass (BG) possess angiogenic potential, and we hypothesized that localized BG presentation would increase neovascularization and promote healing in an irradiated bone defect. An isolated calvarial region of Sprague-Dawley rats was irradiated 2 weeks before surgery. Bilateral critical-sized defects were created and immediately filled with a BG-loaded collagen sponge or an empty sponge as an internal control. Histological analysis of calvaria collected after 2 weeks demonstrated greater neovascularization within the defect in the presence of BG than with collagen alone. Noninvasive ultrasound imaging at 4 weeks detected less contrast agent in the brain below BG-treated defects than in the nearby untreated defects and images of treated defects acquired at 2 weeks. The reduced ability to detect contrast agent in BG-treated defects suggested greater attenuation of ultrasound signal due to early bone formation. Micro-computed tomography imaging at 12 weeks demonstrated significantly greater bone volume fraction within BG-treated defects than in controls. These results suggest that neovascularization induced by localized BG delivery promotes bone regeneration in this highly compromised model of bone healing and may offer an alternative approach to costly growth factors and their potential side-effects.

AB - Localized radiation is an effective treatment modality for carcinomas, yet the associated reduction of the host vasculature significantly inhibits the tissue's regenerative capacity. Low concentrations of bioactive glass (BG) possess angiogenic potential, and we hypothesized that localized BG presentation would increase neovascularization and promote healing in an irradiated bone defect. An isolated calvarial region of Sprague-Dawley rats was irradiated 2 weeks before surgery. Bilateral critical-sized defects were created and immediately filled with a BG-loaded collagen sponge or an empty sponge as an internal control. Histological analysis of calvaria collected after 2 weeks demonstrated greater neovascularization within the defect in the presence of BG than with collagen alone. Noninvasive ultrasound imaging at 4 weeks detected less contrast agent in the brain below BG-treated defects than in the nearby untreated defects and images of treated defects acquired at 2 weeks. The reduced ability to detect contrast agent in BG-treated defects suggested greater attenuation of ultrasound signal due to early bone formation. Micro-computed tomography imaging at 12 weeks demonstrated significantly greater bone volume fraction within BG-treated defects than in controls. These results suggest that neovascularization induced by localized BG delivery promotes bone regeneration in this highly compromised model of bone healing and may offer an alternative approach to costly growth factors and their potential side-effects.

UR - http://www.scopus.com/inward/record.url?scp=67049116466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67049116466&partnerID=8YFLogxK

U2 - 10.1089/ten.tea.2008.0018

DO - 10.1089/ten.tea.2008.0018

M3 - Article

C2 - 18795867

AN - SCOPUS:67049116466

VL - 15

SP - 877

EP - 885

JO - Tissue Engineering - Part A

JF - Tissue Engineering - Part A

SN - 1937-3341

IS - 4

ER -